426

Compound name
Ramucirumab
Alt Name
LY3009806
Cyramza
Compound Image
Ramucirumab.png
Approval Jurisdiction
2014 FDA 2014 EMA
Approved for clinical use
MNSCLC Colorectal Cancer
CAS
947687-13-0
Action
KDR (VEGFR2)
Approved Drug List
1
Commercial Vendor
Eli Lilly